ArticleArchives of osteoporosis2026
Prevalence of Osteoporosis in Elderly Men: Large Real-World Data Addressing the Current Screening Evidence Gap.
Article in Archives of osteoporosis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Evidence supporting osteoporosis screening in older men remains limited. In a large real-world cohort of 29,906 men aged ≥ 70 undergoing DXA screening, osteoporosis was identified in 16.5% and osteopenia in 51.3%, with prevalence increasing with age. These findings indicate that a substantial proportion of older men have low bone mass and are therefore at increased risk of fracture. PURPOSE: Evidence supporting routine osteoporosis screening in older men remains limited. We aimed to evaluate the prevalence and skeletal distribution of low bone mineral density (BMD) in elderly men within a large healthcare system where an age-based DXA screening recommendation has been implemented.
methodsWe conducted a retrospective cohort study of DXA examinations performed between 2014 and 2024 at Assuta Medical Centers within Maccabi Health Services (MHS). MHS implemented a computerized clinical recommendation within the electronic medical record supporting DXA screening in men aged ≥ 70 years approximately a decade ago. To approximate primary age-based screening conditions, individuals with prior DXA examinations before age 70, oncologic disease, prior fracture, chemotherapy or radiotherapy exposure, and other causes of secondary osteoporosis were excluded. Additional exclusions for inflammatory disease, chronic glucocorticoid therapy, and endocrine disorders were applied using structured diagnostic fields and referral free-text data. Participants were required to have at least two valid skeletal site-groups available for analysis.
resultsAmong a total of 29,906 eligible individuals who underwent DXA, osteoporosis prevalence was 15.0% at the femoral neck, 6.1% at the total hip, and 3.8% at the lumbar spine. Using the lowest T-score definition, overall osteoporosis prevalence was 16.5% and 51.3% of participants demonstrated osteopenia. Femoral neck osteoporosis increased from 12.4% in men aged 70-74 years to 26.1% in men aged ≥ 80 years.
conclusionIn a large real-world cohort approximating systematic screening conditions, nearly one in six older men met diagnostic criteria for osteoporosis. These data help address the current evidence gap regarding osteoporosis screening in men.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.